Literature DB >> 11507225

U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids.

A E Reynolds1, B J Ryckman, J D Baines, Y Zhou, L Liang, R J Roller.   

Abstract

The herpes simplex virus type 1 (HSV-1) U(L)34 protein is likely a type II membrane protein that localizes within the nuclear membrane and is required for efficient envelopment of progeny virions at the nuclear envelope, whereas the U(L)31 gene product of HSV-1 is a nuclear matrix-associated phosphoprotein previously shown to interact with U(L)34 protein in HSV-1-infected cell lysates. For these studies, polyclonal antisera directed against purified fusion proteins containing U(L)31 protein fused to glutathione-S-transferase (U(L)31-GST) and U(L)34 protein fused to GST (U(L)34-GST) were demonstrated to specifically recognize the U(L)31 and U(L)34 proteins of approximately 34,000 and 30,000 Da, respectively. The U(L)31 and U(L)34 gene products colocalized in a smooth pattern throughout the nuclear rim of infected cells by 10 h postinfection. U(L)34 protein also accumulated in pleiomorphic cytoplasmic structures at early times and associated with an altered nuclear envelope late in infection. Localization of U(L)31 protein at the nuclear rim required the presence of U(L)34 protein, inasmuch as cells infected with a U(L)34 null mutant virus contained U(L)31 protein primarily in central intranuclear domains separate from the nuclear rim, and to a lesser extent in the cytoplasm. Conversely, localization of U(L)34 protein exclusively at the nuclear rim required the presence of the U(L)31 gene product, inasmuch as U(L)34 protein was detectable at the nuclear rim, in replication compartments, and in the cytoplasm of cells infected with a U(L)31 null virus. When transiently expressed in the absence of other viral factors, U(L)31 protein localized diffusely in the nucleoplasm, whereas U(L)34 protein localized primarily in the cytoplasm and at the nuclear rim. In contrast, coexpression of the U(L)31 and U(L)34 proteins was sufficient to target both proteins exclusively to the nuclear rim. The proteins were also shown to directly interact in vitro in the absence of other viral proteins. In cells infected with a virus lacking the U(S)3-encoded protein kinase, previously shown to phosphorylate the U(L)34 gene product, U(L)31 and U(L)34 proteins colocalized in small punctate areas that accumulated on the nuclear rim. Thus, U(S)3 kinase is required for even distribution of U(L)31 and U(L)34 proteins throughout the nuclear rim. Taken together with the similar phenotypes of the U(L)31 and U(L)34 deletion mutants, these data strongly suggest that the U(L)31 and U(L)34 proteins form a complex that accumulates at the nuclear membrane and plays an important role in nucleocapsid envelopment at the inner nuclear membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507225      PMCID: PMC115125          DOI: 10.1128/jvi.75.18.8803-8817.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo.

Authors:  Y Nishiyama; Y Yamada; R Kurachi; T Daikoku
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

2.  UL34, the target of the herpes simplex virus U(S)3 protein kinase, is a membrane protein which in its unphosphorylated state associates with novel phosphoproteins.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Topology of eukaryotic type II membrane proteins: importance of N-terminal positively charged residues flanking the hydrophobic domain.

Authors:  G D Parks; R A Lamb
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

Review 4.  The DNA sequence of the human cytomegalovirus genome.

Authors:  A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; M S Chee; C A Hutchison; T Kouzarides; J A Martignetti; E Preddie
Journal:  DNA Seq       Date:  1991

5.  Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture.

Authors:  F C Purves; R M Longnecker; D P Leader; B Roizman
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3.

Authors:  K R Jerome; R Fox; Z Chen; A E Sears; H y Lee; L Corey
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

7.  The herpes simplex virus 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells.

Authors:  E O Long; S Rosen-Bronson; D R Karp; M Malnati; R P Sekaly; D Jaraquemada
Journal:  Hum Immunol       Date:  1991-08       Impact factor: 2.850

Review 9.  The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; M A Dalrymple; A J Davison; A Dolan; M C Frame; D McNab; L J Perry; J E Scott; P Taylor
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

10.  The DNA sequence of equine herpesvirus-1.

Authors:  E A Telford; M S Watson; K McBride; A J Davison
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

View more
  177 in total

Review 1.  Herpesvirus assembly and egress.

Authors:  Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells.

Authors:  Philippa M Beard; Naomi S Taus; Joel D Baines
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids.

Authors:  Ashley E Reynolds; Elizabeth G Wills; Richard J Roller; Brent J Ryckman; Joel D Baines
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication.

Authors:  Anja Bubeck; Markus Wagner; Zsolt Ruzsics; Mark Lötzerich; Margot Iglesias; Ila R Singh; Ulrich H Koszinowski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Redistribution of cellular and herpes simplex virus proteins from the trans-golgi network to cell junctions without enveloped capsids.

Authors:  Todd W Wisner; David C Johnson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Nuclear egress of pseudorabies virus capsids is enhanced by a subspecies of the large tegument protein that is lost upon cytoplasmic maturation.

Authors:  Mindy Leelawong; Joy I Lee; Gregory A Smith
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

Review 7.  Breach of the nuclear lamina during assembly of herpes simplex viruses.

Authors:  Lynda A Morrison; Gregory S DeLassus
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

Review 8.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

9.  Mapping of sequences in Pseudorabies virus pUL34 that are required for formation and function of the nuclear egress complex.

Authors:  Lars Paßvogel; Patricia Trübe; Franziska Schuster; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Herpes simplex virus 1 UL47 interacts with viral nuclear egress factors UL31, UL34, and Us3 and regulates viral nuclear egress.

Authors:  Zhuoming Liu; Akihisa Kato; Keiko Shindo; Takeshi Noda; Hiroshi Sagara; Yoshihiro Kawaoka; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.